)

Fredun Pharmaceuticals (539730) investor relations material
Fredun Pharmaceuticals Q1 25/26 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Executive summary
Achieved 52% year-over-year revenue growth in Q1 FY26, reaching INR 119.86 crores, with strong expansion in higher-margin pet healthcare verticals.
Net profit rose 64% to INR 6.77 crores, and EPS increased over 63% to 14.33 year-over-year.
Order book exceeds INR 200 crores, providing strong visibility for upcoming quarters.
Board approved unaudited financial results for the quarter ended 30 June 2025 and received a limited review report from statutory auditors with an unmodified conclusion.
Strategic focus on branded generics, pet care, nutraceuticals, and mobility aids, with a shift from OEM to own brands.
Financial highlights
EBITDA grew 62% year-over-year to INR 16.99 crores, with margin expansion to 14.18%.
Consolidated revenue for the quarter ended 30 June 2025 was ₹11,985.50 lakhs, compared to ₹7,881.08 lakhs in the same quarter last year.
Net profit for the quarter was ₹676.58 lakhs, up from ₹412.99 lakhs year-over-year.
Basic and diluted EPS for the quarter stood at ₹14.33, compared to ₹8.79 in the same quarter last year.
Inventory stands at over INR 200 crores; receivables as of July 31 are under INR 100 crores, with receivable days at 120–130.
Outlook and guidance
Targeting to double revenue and PAT in 3–4 years, aiming for INR 800+ crore top line and INR 90+ crore PAT, with PAT margin of 10–11%.
Vintage business expected to grow 15–20% year-over-year, supported by 1,290 product registrations in the pipeline.
New Age business (pet care, nutrition, mobility, wellness) expected to grow at 35–40% CAGR.
By FY29, entire revenue to be driven by vintage generics; by FY32, over 51% from New Age business.
Financial results were prepared in compliance with Ind AS and reviewed by statutory auditors, indicating continued adherence to regulatory and accounting standards.
Next Fredun Pharmaceuticals earnings date

Next Fredun Pharmaceuticals earnings date

The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
)
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
)
I can't remember the last time an app had such a positive impact on my investment process.
)
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
)
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
I can't remember the last time an app had such a positive impact on my investment process.
)
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
)
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
)
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage